A Multiple Ascending Dose Study of ETC-1002 in Healthy Subjects

Clinical trial NCT01485146 · COMPLETED

Trial details

NCT number: NCT01485146
Sponsor: Esperion Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety Evaluation of Escalating Doses

Start date: 2011-10-25
Primary completion: 2012-01-25
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.